CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab

Name: CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab
License: Public Domain

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hepatocellular-carcinoma

intermediate stage of hepatocellular carcinoma, hepatocellular carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208434
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.